LGM
ASLN

Logos Global Management’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

Logos Global Management’s Portfolio ASLN Stock Details ASLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-50,000
Closed -$6.6M – 69
2021
Q2 		$6.6M Sell
50,000
-7,500
-13% -$938K 0.55% 44
2021
Q1 		$7.71M Buy
+57,500
New +$7.29M 0.75% 25

Other funds holding ASLN

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Logos Global Management's ASLN Position: Q3 2021 in Review

Logos Global Management sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q3 2021, closing a stake of 50,000 shares — an estimated $6.6M sold.

Logos Global Management first reported a position in ASLN in Q1 2021 and held it in 2 quarters. The position peaked at $7.71M in Q1 2021. 37 funds tracked by Wall St. Rank hold ASLN as of Q3 2021.

  • Logos Global Management reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q3 2021 after selling out during the quarter.
  • Logos Global Management sold 50,000 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q3 2021, an estimated $6.6M.
  • Logos Global Management first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q1 2021 and held it in 2 quarters.
  • Logos Global Management's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $7.71M in Q1 2021.
  • 37 funds tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q3 2021.

Based on Logos Global Management's 13F filing for Q3 2021, filed 15 Nov 2021.